Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Sweden / NCT05155878
Recruiting Observational

Prognostic Factors in Periampullary Tumors and Cysts

NCT05155878 · tracked via the Priya Life Science Sweden tracker
Sponsor
Umeå University
Phase
Observational
Started
2021-09-01
Last updated
2022-01-05

Condition(s) studied

Pancreas CancerPancreas NeoplasmPancreas CystPancreatic FistulaPancreas DiseaseBile Duct CancerPeriampullary CancerSurgerySurgery--Complications

Study summary

The project aims at analysing prognostic and predictive factors involved in diagnostics and surgical treatment of cysts and tumors in the pancreas and periampullary region using both clinical data and blood and tissue samples for biomarker development and validation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Recommended surgery for tumor or cyst in the pancreas or periampullary region * Information avalible in electronic journal files * Informed consent (or deceased for retrospective part of the study) Exclusion Criteria: * No informed consent (and still alive at study initiation)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Surgical Clinic at Umeå University Hospital Umeå Sweden Recruiting

More Umeå University trials in Sweden

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer Recruiting
Dual vs. Single-Antibiotic Impregnated Cement in Hemiarthroplasty for Femoral Neck Fracture Active, not recruiting
Heparin-binding Protein and Lungedema in ICU Patients. Recruiting
Single-Stapled Technique for Colorectal Anastomosis Recruiting
Abdominal Rectus Diastasis Microscopy and Rehabilitation (AMIRE) Active, not recruiting

Other trials for the same condition

Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer Recruiting
Treatment of Distal Malignant Biliary Obstruction by Uncovered, Partially Covered, or Fully Covered Metal Stents Active, not recruiting
Promoting Sleep to Alleviate Pain - Arthroplasty Recruiting
The Effect of the Covid-19 Pandemic Among Operated Patients Recruiting
Effects of Prone Position After Major Abdominal Surgery Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05155878 on ClinicalTrials.gov ↗ ← All trials in Sweden